Dr. Skerrett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
505 Fifth Avenue
New York, NY 10017Phone+1 212-880-2060- Is this information wrong?
Education & Training
Columbia UniversityMSC, Public Health-BioStatistics, 2001 - 2003
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1987 - 1989
Baylor College of MedicineResidency, Internal Medicine, 1984 - 1987
Lewis Katz School of Medicine at Temple UniversityClass of 1984- University of PennsylvaniaBA, Biology, 1975 - 1979
Certifications & Licensure
NY State Medical License 1988 - 2026
NJ State Medical License 2003 - 2009- American Board of Internal Medicine Internal Medicine
- American Board of Pathology Blood Banking/Transfusion Medicine
Clinical Trials
- Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF) Start of enrollment: 2007 Oct 01
- Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction Start of enrollment: 2008 Mar 01
- Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion Start of enrollment: 2008 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 38 citationsSafety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following ant...Yuanyuan Wang, Andrew Shimmin, Peter Ghosh, Paul Marks, James M. Linklater, David Connell, Stephen Hall, Donna Skerrett, Silviu Itescu, Flavia M. Cicuttini> ;Arthritis Research & Therapy. 2017 Aug 2
- 140 citationsA Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure.Emerson C. Perin, Kenneth M. Borow, Guilherme V. Silva, Anthony N. DeMaria, Oscar C. Marroquin, Paul P Huang, Jay H. Traverse, Henry Krum, Donna Skerrett, Yi Zheng, Ja...> ;Circulation Research. 2015 Aug 28
- Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary LVADs.Ascheim, D. D.,Gelijns, A. C.,Goldstein, D.,Moye, L. A.,Smedira, N.,Lee, S.,Klodell, C. T.,Szady, A.,Parides, M. K.,Jeffries, N.,Skerrett, D.,Taylor, D. A.,Rame, J. E....> ;Circulation. 2014 Apr 01
- Join now to see all
Press Mentions
Paradigm Achieves Primary Endpoint in PARA_OA_008 Synovial Fluid Biomarker Phase 2 Clinical TrialOctober 6th, 2022- Paradigm Doses First Subjects in Phase III Knee Osteoarthritis TrialMay 5th, 2022
- First Subjects Randomized and Dosed in the U.S. Under Phase III Pivotal Trial for the Treatment of Pain Associated with Knee OAMay 4th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
